Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Shockwave Medical’s new coronary IVL catheter, now twice as fast, impresses after 30 days
The new-look device was designed to deliver 10 pulses to severely calcified coronary lesions in five seconds. Early data linked the catheter with positive 30-day safety and effectiveness outcomes.
Nearly half of all surgeons have considered leaving the profession due to burnout
Burnout remains one of the biggest issues in modern healthcare. More than 1,500 surgeons, including many from the field of cardiac surgery, provided feedback for a new report on that very topic.
Medtronic to acquire medtech company Scientia Vascular for $550M
Scientia Vascular, a Salt Lake City-based medtech company focused on developing new vascular devices, was founded in 2007 and has more than 300 employees.
Next-generation guide extension catheter delivers value during complex PCI
The CrossFAST system was successfully used to deploy multiple stents after other devices fell short.
AATS wants to improve research in the field of cardiothoracic surgery
The American Association for Thoracic Surgery has announced a new partnership with the Cardiothoracic Surgical Trials Network. The groups plan on working together to address current challenges in cardiothoracic surgery research.

Shockwave Medical’s new coronary IVL catheter, now twice as fast, impresses after 30 days

The new-look device was designed to deliver 10 pulses to severely calcified coronary lesions in five seconds. Early data linked the catheter with positive 30-day safety and effectiveness outcomes.

Nearly half of all surgeons have considered leaving the profession due to burnout

Burnout remains one of the biggest issues in modern healthcare. More than 1,500 surgeons, including many from the field of cardiac surgery, provided feedback for a new report on that very topic.

Medtronic to acquire medtech company Scientia Vascular for $550M

Scientia Vascular, a Salt Lake City-based medtech company focused on developing new vascular devices, was founded in 2007 and has more than 300 employees.

Angiography demonstrates a high-grade, modestly angulated stenosis (arrow) in the proximal segment of a large diagonal branch (A). Predilation performed with difficulty, and the GEC could not be advanced beyond stenosis even with “inch worming” techniques. (B). Advancement of the CrossFAST (C) beyond the proximal stent edge stenosis (a.), the position of the distal end of the outer catheter (b.), and the microcatheter tip (c.) are indicated.

Next-generation guide extension catheter delivers value during complex PCI

The CrossFAST system was successfully used to deploy multiple stents after other devices fell short.

AATS wants to improve research in the field of cardiothoracic surgery

The American Association for Thoracic Surgery has announced a new partnership with the Cardiothoracic Surgical Trials Network. The groups plan on working together to address current challenges in cardiothoracic surgery research.

Newsweek ranked the 50 best heart hospitals in the world

Moderate valve oversizing during TAVR boosts survival—too much may be less beneficial

Oversizing transcatheter heart valves can improve TAVR outcomes. There is still a reason to be cautious, however, especially when patients are receiving a balloon-expandable valve.

American College of Cardiology announces late-breaking clinical trials for ACC.26

The American College of Cardiology's 2026 annual meeting will include an all-time record of 60 late-breaking clinical studies.

Blood filtration company fined $5.7M, executive charged, for covering up patient deaths

The U.S. Department of Justice said ExThera cooperated with the investigation into a failure to file adverse event notices with the Food and Drug Administration after two cancer patients who used its blood filtration systems in Antigua died shortly after returning home. The California-based company’s former chief regulatory officer has agreed to plead guilty and could serve prison time.